This consensus combined with the latest research progress at home and abroad, has an in-depth discussion on the early identification of neonatal MPP, the selection and application of laboratory detection methods, the treatment of neonatal MPP, the handling principles of severe cases and other key issues. And put forward practical and authoritative suggestions, to provide scientific and effective guidance for clinical practice.

Both mycoplasma and chlamydia belong to the broad category of bacteria, between bacteria and viruses in size, and contain both DNA and RNA. They are different from viruses because viruses have either DNA or RNA, not both. Therefore, it is classified as bacteria.

Mycoplasma pneumoniae is a pathogenic microorganism between viruses and bacteria, it mainly causes respiratory infections, upper respiratory infections and acute bronchitis are the most common, about 5-10% will develop pneumonia, called mycoplasma pneumonia. Mycoplasma has no cell wall in its structure, so it is resistant to antibiotics such as penicillin and cephalosporin that target the cell wall.

Mycoplasma pneumoniae (MP) is a microorganism that falls between a virus and a typical bacterium, belonging to the genus Mycoplasma. It can attach to the surface of the respiratory mucosa, causing lung infections. Due to the lack of cell wall structure found in bacteria, Mycoplasma pneumoniae is resistant to antibiotics that target bacterial cell walls, such as penicillin and cephalosporin.

Recently, Mycoplasma pneumoniae has been highly prevalent. Since there is currently no available vaccine for Mycoplasma pneumoniae, it is important to develop good disease management habits to prevent infection. Here are some tips:

Mycoplasma pneumoniae is an atypical pathogen. It is neither a virus nor a bacterium, but a microorganism intermediate in size between a bacterium and a virus.

The clinical application of the colloidal gold method rapid detection program for mycoplasma pneumonia infections holds significant importance in the field of healthcare.

Respiratory infections are a significant global health concern, affecting millions of individuals each year. Among the various pathogens responsible for respiratory infections, Mycoplasma pneumoniae, a bacterium commonly known as "atypical pneumonia," and has gained attention due to its increasing prevalence and potential complications.

Recently, another infectious disease, mycoplasma pneumonia, has also entered a high incidence period.